89 related articles for article (PubMed ID: 32962737)
1. Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease.
Yamaguchi-Takegami N; Takahashi A; Mitsui J; Sugiyama Y; Chikada A; Porto KJL; Takegami N; Sakuishi K; Ishiura H; Yamada K; Shimizu J; Tsuji S; Toda T
Intern Med; 2024 Mar; 63(6):861-865. PubMed ID: 37558486
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease.
Parente DB; de Melo Malta FCM; de Souza Cravo R; Luiz RR; Rotman V; Perez RM; Rodrigues RS
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38642092
[TBL] [Abstract][Full Text] [Related]
3. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk in Patients with Gaucher Disease Using Real-World Data.
Revel-Vilk S; Zimran A; Istaiti M; Azani L; Shalev V; Chodick G; Manor O; Paltiel O
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137776
[TBL] [Abstract][Full Text] [Related]
5. FindZebra online search delving into rare disease case reports using natural language processing.
Liévin V; Hansen JM; Lund A; Elstein D; Matthiesen ME; Elomaa K; Zarakowska K; Himmelhan I; Botha J; Borgeskov H; Winther O
PLOS Digit Health; 2023 Jun; 2(6):e0000269. PubMed ID: 37384616
[TBL] [Abstract][Full Text] [Related]
6. Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease.
Valero-Tena E; Roca-Espiau M; Verdú-Díaz J; Diaz-Manera J; Andrade-Campos M; Giraldo P
Front Med (Lausanne); 2023; 10():1098472. PubMed ID: 37250646
[TBL] [Abstract][Full Text] [Related]
7. Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish.
Mignani L; Guerra J; Corli M; Capoferri D; Presta M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902174
[TBL] [Abstract][Full Text] [Related]
8. Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study.
Do YR; Choi Y; Heo MH; Kim JS; Yoon JH; Lee JH; Park JS; Sohn SK; Kim SH; Lim S; Chung JS; Jo DY; Eom HS; Kim H; Jeon SY; Won JH; Lee HJ; Shin JW; Jang JH; Yoon SS
Blood Res; 2022 Sep; 57(3):207-215. PubMed ID: 35880496
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease - more than just a rare lipid storage disease.
Roh J; Subramanian S; Weinreb NJ; Kartha RV
J Mol Med (Berl); 2022 Apr; 100(4):499-518. PubMed ID: 35066608
[TBL] [Abstract][Full Text] [Related]
10. Novel Management and Screening Approaches for Haematological Complications of Gaucher's Disease.
Giraldo P; Andrade-Campos M
J Blood Med; 2021; 12():1045-1056. PubMed ID: 34908889
[TBL] [Abstract][Full Text] [Related]
11. Economic burden and health related quality of life of ultra-rare Gaucher disease in China.
Qi X; Xu J; Shan L; Li Y; Cui Y; Liu H; Wang K; Gao L; Kang Z; Wu Q
Orphanet J Rare Dis; 2021 Aug; 16(1):358. PubMed ID: 34380529
[TBL] [Abstract][Full Text] [Related]
12. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
[TBL] [Abstract][Full Text] [Related]
13. Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Mistry PK; Batista JL; Andersson HC; Balwani M; Burrow TA; Charrow J; Kaplan P; Khan A; Kishnani PS; Kolodny EH; Rosenbloom B; Scott CR; Weinreb N
Am J Hematol; 2017 Sep; 92(9):929-939. PubMed ID: 28569047
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.
Andrade-Campos M; Alfonso P; Irun P; Armstrong J; Calvo C; Dalmau J; Domingo MR; Barbera JL; Cano H; Fernandez-Galán MA; Franco R; Gracia I; Gracia-Antequera M; Ibañez A; Lendinez F; Madruga M; Martin-Hernández E; O'Callaghan MDM; Del Soto AP; Del Prado YR; Sancho-Val I; Sanjurjo P; Pocovi M; Giraldo P
Orphanet J Rare Dis; 2017 May; 12(1):84. PubMed ID: 28468677
[TBL] [Abstract][Full Text] [Related]
16. [Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases].
Giraldo P; Pérez-Calvo J; Cortés T; Civeira F; Rubio-Félix D
Sangre (Barc); 1994 Feb; 39(1):3-7. PubMed ID: 8197516
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease.
Andrade-Campos MM; de Frutos LL; Cebolla JJ; Serrano-Gonzalo I; Medrano-Engay B; Roca-Espiau M; Gomez-Barrera B; Pérez-Heredia J; Iniguez D; Giraldo P
Orphanet J Rare Dis; 2020 Sep; 15(1):256. PubMed ID: 32962737
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
